Additionally, previous research has indicated that miR-124 can serve as a biomarker to diagnose depression, and that the inhibition of miR-124 may help relieve depression by way of regulating the BDNF-TrkB signaling pathway (Wang et al., 2017). Here, NTRK2 is linked to major depressive disorder.